Sign inJoin waitlistJoin the waitlist

DF

David Fivenson

Physician · Trinity Health Michigan

Credentials: · · · ·

History

Trinity Health Michigan
Present

Hillcrest Medical Center at University of California San Diego Health
1988–1989
University of Cincinnati Medical Center
1985–1988
Trinity Health
1984–1985
University of Michigan Medical School
1980–1984

Research

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
Journal of Clinical Oncology · 2001 · 468 citations
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Journal of the American Academy of Dermatology · 2008 · 454 citations
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Journal of the American Academy of Dermatology · 2020 · 262 citations

BN
Brian Nickoloff
9 papers
LS
Luba Scherschun
7 papers · 7 as a resident
Victoria Werth
7 papers
BS
Brian Schapiro
6 papers
Debra Breneman
6 papers
Donna Culton
4 papers
JR
James Ramirez
4 papers
LG
Linda Stein Gold
4 papers · 1 as a resident
Aimee Payne
3 papers
AK
Andrew Kontos
3 papers · 3 as a fellow
Ann Martin
3 papers
Anthony Fernandez
3 papers

Clinical trials

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
Principal investigator · Completed · Phase 3
LEO Pharma
2010–2011
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Site PI · Recruiting
Sanofi
2025–2034
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Site PI · Recruiting · Phase 4
Eli Lilly and Company
2025–2028